Department of Pediatrics, Government Medical College, Nagpur, India.
Indian Pediatr. 2012 Nov;49(11):911-3. doi: 10.1007/s13312-012-0217-z. Epub 2012 Jun 10.
Although sickle cell anemia in India is believed to have a mild clinical presentation, few studies report severe disease in many patients from central India. Hence, we have retrospectively studied 316 children with SCA who were followed up for a period of 5.8±5.7 years. There were 55.4 blood transfusions, 43.3 episodes of vaso-occlusive crises requiring hospitalization, and 108.9 hospitalizations per 100 person years. Ninety six (30%) patients had severe disease whereas 74 patients also fulfilled the criteria for hydroxyurea therapy. Significant proportion of children with sickle cell anemia from central India present with severe clinical presentation and require regular medical attention.
虽然人们认为印度的镰状细胞贫血症临床表现较轻,但来自印度中部的许多患者的严重疾病鲜有报道。因此,我们回顾性研究了 316 名镰状细胞贫血症患儿,这些患儿的随访时间为 5.8±5.7 年。有 55.4 次输血,43.3 次需要住院治疗的血管阻塞性危象发作,以及每 100 人年有 108.9 次住院治疗。96 名(30%)患者患有严重疾病,而 74 名患者也符合羟基脲治疗标准。来自印度中部的镰状细胞贫血症患儿中有相当大的比例表现出严重的临床表现,需要定期就医。